Primorigen Biosciences, Madison, has received a $1.2 million Phase 2 Small Business Innovation Research grant from the National Institutes of Health. Read the full Wisconsin State Journal story here.
Primorigen Biosciences, Madison, has received a $1.2 million Phase 2 Small Business Innovation Research grant from the National Institutes of Health. Read the full Wisconsin State Journal story here.